Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment

BACKGROUND: Remission, the primary goal of treatment for major depressive disorder (MDD), is the absence of significant signs or symptoms and the return to a state of normal functioning. A recent study found that the level of brain-derived neurotrophic factor (BDNF) increased after antidepressant tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Bun-Hee, Park, Young-Min, Um, Tae Hyun, Kim, Sollip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114913/
https://www.ncbi.nlm.nih.gov/pubmed/25092985
http://dx.doi.org/10.2147/NDT.S64913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114913/
https://www.ncbi.nlm.nih.gov/pubmed/25092985
http://dx.doi.org/10.2147/NDT.S64913

Ejemplares similares